Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with ...

Company delivers “Rule of 50” Performance in 2024 with 25% ARR growth and 25% adjusted EBITDA marginFourth-quarter 2024 revenue of $109.0 million ...

Since announcing its intent to pursue FedRAMP authorization, the Cellebrite Government Cloud was reviewed by a Third-Party Assessment Organization (3PAO), and the FedRAMP Program Management Office ...

AMTD is the exclusive rights holder of L'OFFICIEL and its associated brands. The first L'OFFICIEL magazine was published in Paris in 1921, and today, we publish and distribute iconic fashion and ...

Heimar Profits 8.2 billion in 2024 - Continued Real Revenue Growth and Strong Cost Control Key Highlights of the Annual Financial Report Operating revenue amounted to ISK 14.8 billion in 2024, with ...

Senior Vice President, Investor Relations and Corporate Development [Commercial break] Good day, everyone, and welcome to ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

Good morning, and welcome to the Hyatt Fourth Quarter and Full Year 2024 Earnings Conference call. At this time, all participants are in a listen only mode. After the speakers' remarks, we'll have a ...

A look at the nine reports the Jacksonville Office of Inspector General issued in 2024 and the two so far this year.

Türkiye High Level Strategic Cooperation Council in a joint declaration after its 7th session on Thursday pledged to further ...